Chicago Marathon Runner Finishes Race Cancer-Free and With New Liver
“One year after delaying a liver transplant to run the 2023 Chicago Marathon, Batbayar Tserendorj has a new liver, is cancer-free and completed the 2024 race, according to Northwestern Medicine (NM). Last year, Tserendorj then age 60, was living with liver cancer and on the waiting list for a new liver. He had been diagnosed with liver cancer in early 2023, likely caused by chronic hepatitis B and D infections, according to Northwestern Medicine.”
Endoscopies at Vanderbilt exposed patients to HIV, hepatitis C
“Nashville-based Vanderbilt Health is notifying patients that they may have been exposed to hepatitis B, hepatitis C and HIV as a result of botched endoscopy procedures performed at a clinic located on the hospital’s main campus.”
Coincidence of HCV and chronic kidney disease-a systematic review and meta-analysis
“Conclusions – We found a strong correlation between HCV infection and a higher risk of chronic renal disease in general global population.”
UB researchers advocate for continuing fewer rules for telemedicine
“During the COVID-19 pandemic, the federal government loosened regulations that govern the use of telemedicine for patients, which are set to expire on Dec 31. With a few months to go, an extension is possible. Some UB researchers and clinicians believe that returning to pre-pandemic restrictions would have a profoundly negative impact on health care.”
Study Identifies Risk Factors for Liver Enzyme Elevation Following Hepatitis C Virologic Cure
“Key Takeaways – Higher pretreatment ALT and cirrhosis increase liver enzyme elevation risk in HCV patients post-virologic response. Male sex is linked to reduced odds of liver enzyme elevation after HCV treatment.”
With October Being Liver Awareness Month, an Opportunity to Acknowledge This Essential Organ
“It is time to celebrate researchers’ amazing identification of our the body’s big secret—liver cells! These silent miraculous unrecognized liver cells have been hiding inside our noncomplaining, liver.”
Pharmacy-Based Services Combat SUD, HIV, STI Syndemic-Related Harms
“Pharmacies can play a crucial role in access to care by providing harm reduction, sexually transmitted infection (STI), and hepatitis C virus (HCV) services, according to a new study published in the Journal of the American Pharmacists Association. The findings show that by offering patient incentives, pharmacies can increase testing and detection of infectious diseases among individuals who might not otherwise seek care.”
HCV Transmission: What Are the Trends in HCV Without Injection Drug Use?
“Hepatitis C virus (HCV) infection among individuals without a history of injection drug use (IDU) is “sizeable” despite the higher HCV rates among those with a history of IDU, according to study findings published in Liver International. The primary mode of HCV transmission is through IDU. However, transmission can occur in the absence of IDU, through sexual contact, household contact, occupational exposure, and dialysis or transfusion, among other means.”
HCV Linked to Increased Risk of Peripheral Artery Disease in Hemodialysis Patients
“Key Takeaways – HCV infection in ESRD patients on hemodialysis is linked to increased PAD risk, indicated by elevated baPWV levels. Higher HCV viral loads and genotype 1 are significantly associated with increased PAD risk in these patients.”
Video
First-Hand Insights into Treating Hepatitis C in Pregnancy
“At IDWeek, the session “Should HCV Be Treated in Pregnant Persons?” featured Catherine Chappell, MD, MSc, assistant professor at the University of Pittsburgh. Chappell, an obstetrician-gynecologist with training in reproductive infectious disease, family planning, and addiction medicine, discussed ongoing studies on direct-acting antivirals for treating hepatitis C in pregnancy.”
